Health Secretary Robert F. Kennedy Jr.'s drastic funding cuts to mRNA vaccine research could stymie medical breakthroughs and push scientific talent away from the U.S., experts warn.
Former Surgeon General Dr. Jerome Adams warns that the U.S. risks lives by cutting funding for mRNA vaccine research, following Secretary Kennedy's controversial decision to halt key projects.
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
Vaccine experts are divided over the Trump administration's Generation Gold Standard project aimed at creating a universal flu vaccine. While some praise the initiative, others question its outdated methods and hefty price tag.
The U.S. Department of Health and Human Services is on a bold mission to develop a universal flu vaccine within four years, a project that could revolutionize how we combat influenza and prepare for future pandemics. Funded by $500 million, this initiative aims for FDA approval by 2029, with clinical trials starting soon. Experts weigh in on the challenges and potential of this ambitious project.
In a controversial move, NIH officials may be pushing to eliminate mRNA vaccine technology from grant applications, signaling a potential halt in vital medical research. Scientists express fears over job security and funding.
